Allergan, Inc. : AGN

All AGN Articles

189 Articles

Lee Jackson | Feb 7, 2019 at 7:25 AM EST

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

A new addition to the Merrill Lynch US 1 list, plus four additional stocks that offer a fair degree of…

Jon C. Ogg | Jan 31, 2019 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell,…

Jon C. Ogg | Jan 30, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Apple, Carnival, Ciena, Juniper Networks, Lockheed Martin, Plug…

Chris Lange | Jan 29, 2019 at 4:08 PM EST

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a down day for the broad U.S. markets. We are now in the busiest week of this earnings…

Lee Jackson | Nov 9, 2018 at 7:05 AM EST

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all…

Jon C. Ogg | Aug 23, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Trey Thoelcke | Aug 13, 2018 at 1:15 PM EDT

Tesla, Schlumberger and 4 Others With Recent Golden Crosses or Death Crosses

Golden crosses, typically seen as a bullish sign, recently happened to shares of Tesla and others, while death crosses, a…

Jon C. Ogg | Jul 5, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Cheniere, Clean Energy, Facebook, Fiat Chrysler, Intel, NetApp and More

The top analyst upgrades, downgrades and other research calls from Thursday include Allergan, Cheniere Energy, Clean Energy, Facebook, Fiat Chrysler,…

Jon C. Ogg | Jul 3, 2018 at 10:50 AM EDT

Merrill Lynch Issues Top 8 US Stock Ideas for Q3 2018

Merrill Lynch released its high-conviction ideas for the third quarter ahead of the Independence Day holiday. These picks are based…

Lee Jackson | May 10, 2018 at 10:05 AM EDT

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some…

Jon C. Ogg | Apr 24, 2018 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp, Nvidia, Vale and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp,…

Lee Jackson | Mar 21, 2018 at 8:45 AM EDT

Merrill Lynch Makes Surprising Technology Addition to US 1 List

Here are the latest addition to the Merrill Lynch US 1 list and three current list members that have big…

Paul Ausick | Mar 5, 2018 at 4:04 PM EST

Dermira, Allergan Plunge into Monday’s 52-Week Low Club

Dermira, BRF, Park Hotels & Resorts, and Allergan all posted new 52-week lows Monday.

Lee Jackson | Mar 1, 2018 at 8:10 AM EST

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

While chasing what portfolio managers own isn’t always the best idea, many people have made a lot of money by…

1 2 3 4 … 13

Allergan, Inc. : AGN

All AGN Articles

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Tuesday’s Biggest Winners and Losers in the S&P 500

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Tesla, Schlumberger and 4 Others With Recent Golden Crosses or Death Crosses

Top Analyst Upgrades and Downgrades: Allergan, Cheniere, Clean Energy, Facebook, Fiat Chrysler, Intel, NetApp and More

Merrill Lynch Issues Top 8 US Stock Ideas for Q3 2018

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

Top Analyst Upgrades and Downgrades: Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp, Nvidia, Vale and More

Merrill Lynch Makes Surprising Technology Addition to US 1 List

Dermira, Allergan Plunge into Monday’s 52-Week Low Club

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

“Did you buy It from the mob?”: Dave Ramsey hosts floored by 21-year-old’s 30% truck loan

Kevin Warsh Would Be a Hawk at the Fed, but Productivity Boom Could Prevail

Ray Dalio: ‘We’re On the Brink’ of Major Problems Within 2 Years

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

“Did you buy It from the mob?”: Dave Ramsey hosts floored by 21-year-old’s 30% truck loan

Kevin Warsh Would Be a Hawk at the Fed, but Productivity Boom Could Prevail

Allergan, Inc. : AGN

All AGN Articles

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Tuesday’s Biggest Winners and Losers in the S&P 500

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Tesla, Schlumberger and 4 Others With Recent Golden Crosses or Death Crosses

Top Analyst Upgrades and Downgrades: Allergan, Cheniere, Clean Energy, Facebook, Fiat Chrysler, Intel, NetApp and More

Merrill Lynch Issues Top 8 US Stock Ideas for Q3 2018

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

Top Analyst Upgrades and Downgrades: Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp, Nvidia, Vale and More

Merrill Lynch Makes Surprising Technology Addition to US 1 List

Dermira, Allergan Plunge into Monday’s 52-Week Low Club

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

“Did you buy It from the mob?”: Dave Ramsey hosts floored by 21-year-old’s 30% truck loan

Kevin Warsh Would Be a Hawk at the Fed, but Productivity Boom Could Prevail

Ray Dalio: ‘We’re On the Brink’ of Major Problems Within 2 Years

Featured Reads

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Half of America Still Feels Financially Exposed Despite 8% Jump in Security